Understanding the mechanisms by which Parkin and PINK1 interact with the STING pathway opens new avenues for therapeutic interventions in Parkinson’s disease and potentially other neurodegenerative disorders characterized by mitochondrial dysfunction and inflammation. This evidence concerns the gene STING1 and Parkinson disease.